Cholecystokinin (CCK) and schizophrenia: the selective CCK B antagonist LY262691 decreases midbrain dopamine unit activity
Autor: | Rasmussen, Kurt, Stockton, Marsha E., Czachura, Janet F., Jeffry Howbert, J. |
---|---|
Zdroj: | In European Journal of Pharmacology 1991 209(1):135-138 |
Databáze: | ScienceDirect |
Externí odkaz: |